OBI Pharma Showcases Next-Generation ADC Development at 2025 World ADC Asia Summit

OBI Pharma (4174.TWO) participated in the 4th World ADC Asia Summit, held from June 10 to 12 in Incheon, Korea, with three featured presentations, one expert panel discussion, and three poster sessions—showcasing its latest research achievements in the field of antibody-drug conjugates (ADCs) and demonstrating the growing industry recognition of its expertise in this field.